Diagnosis. Anti-TNF-agent induced psoriasiform skin rash. Management. Discontinuation of anti-TNF therapy. The patient opted to have his gastrointestinal symptoms treated with oral mesalazine and ...

This confirmed the diagnosis of an anti-TNF-agent-induced psoriasiform skin rash. The skin manifestations caused the patient sufficient distress to prevent further use of a TNF antagonist.

Miliaria rubra is a type of heat rash or prickly heat that happens when sweat becomes trapped under the skin. Children tend to get it more than adults because their sweat glands are still developing.

He has flat erythema that is more prominent on the upper chest, neck, and head. The rash produces a constant mild generalized sunburn sensation and is more severe during flares. He has sporadic ...

Please provide your email address to receive an email when new articles are posted on . Percent-predicted FEV 1, sweat chloride and safety were analyzed in two phase 3 trials of vanzacaftor ...

FDA approval of ALYFTREK and TRIKAFTA expands CF treatment options to over 300 mutations, benefiting 300 newly eligible U.S. patients. Suzetrigine for acute pain aligns with NOPAIN Act ...

“In Phase 3 clinical trials, across a broad range of genotypes, once-daily ALYFTREK demonstrated non-inferiority to TRIKAFTA in ppFEV ... potentially fatal drug-induced liver injury and liver ...

Mind-body therapies like meditation, psychotherapy, and deep breathing may help reduce stress levels, potentially reducing ...

NHS England has agreed a deal with Vertex for its three-drug cystic fibrosis therapy Kaftrio, just days after the EMA’s human medicines committee recommended approval of the drug. The deal means ...

Skin (cutaneous) lymphomas often manifest as a skin rash. Although usually identified early, skin lymphomas can be mistaken for other skin conditions, delaying diagnosis. Non-Hodgkin's lymphoma (NHL) ...